Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment.

导出 OA

翻译打印收藏纠错

作者： Aleš,Kvasnička ^[1] ; David,Friedecký ^[1] ; Radana,Brumarová ^[1] ; Markéta,Pavlíková ^[2] ; Kateřina,Pavelcová ^[3] ; Jana,Mašínová ^[3] ; Lenka,Hasíková ^[3] ; Jakub,Závada ^[3] ; Karel,Pavelka ^[3] ; Pavel,Ješina ^[4] ; Blanka,Stibůrková ^[5]

作者单位： Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic. ^[1] Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic. ^[2] Institute of Rheumatology, Na Slupi 4, 128 50 Prague 2, Prague, Czech Republic. ^[3] Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. ^[4] Institute of Rheumatology, Na Slupi 4, 128 50 Prague 2, Prague, Czech Republic. stiburkova@revma.cz. ^[5] Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. stiburkova@revma.cz. ^[6]

关键词 Glycerophospholipids Gout Hyperuricemia LC–MS Lipidomics Urate-lowering treatment

主题词人类(Humans);高尿酸血症(Hyperuricemia);尿酸(Uric Acid);痛风(Gout);抗痛风药(Gout Suppressants)

DOI 10.1186/s13075-023-03204-6

PMID 38042879

发布时间 2024-02-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交